Immunovant, Inc. vs Pfizer, Inc. — Stock Comparison

IMVT
Immunovant, Inc.
$27.12
▼ 0.09%
vs
PFE
Pfizer, Inc.
$26.33
▼ 1.39%
Q·Score Winner
Pfizer, Inc.
PFE6.5/10vs 5.1/10

Q·Score Breakdown

5.1
Bearish
Overall
6.5
Neutral
1.6
Quality
7.4
6.7
Health
7
5.6
Growth
5.6
5.7
Valuation
6.7
7.1
Sentiment
5.2
IMVT

72% of 18 covering analysts have a positive rating.

low return on equity (-69%).

PFE

Strong profitability with 12% net profit margins.

analyst sentiment is cautious.

Analyst Consensus

BUY
Target $40.29 (+48.6%)
17 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts

Fundamentals

IMVT
PFE
Trailing P/E
19.4×
-10.5×
Forward P/E
9.4×
0.0%
Profit Margin
12.4%
0.0%
Gross Margin
75.8%
-69.3%
ROE
8.9%
Revenue Growth
-1.2%
Earnings Growth
0.67
Beta
0.39
Price / Book
$5.5B
Market Cap
$149.8B
$13 – $30
52-Week Range
$22 – $29

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →